Laddar...
Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions
Cancer immunotherapy has been revolutionized by the development of monoclonal antibodies (mAbs) that inhibit interactions between immune checkpoint molecules, such as programmed cell-death 1 (PD-1), and its ligand PD-L1. However, mAb-based drugs have some drawbacks, including poor tumor penetration...
Sparad:
| I publikationen: | Int J Mol Sci |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279355/ https://ncbi.nlm.nih.gov/pubmed/32455628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21103639 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|